Literature DB >> 28066561

High-density lipoprotein: quantity or quality?

Konstantinos Tziomalos1.   

Abstract

Year:  2016        PMID: 28066561      PMCID: PMC5179451          DOI: 10.21037/jtd.2016.11.67

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

Review 1.  Atherogenesis in renal patients: a model of vascular disease?

Authors:  Georgios Efstratiadis; Konstantinos Tziomalos; Dimitri P Mikhailidis; Vasilios G Athyros; Apostolos Hatzitolios
Journal:  Curr Vasc Pharmacol       Date:  2008-04       Impact factor: 2.719

Review 2.  Unresolved issues in lipid-lowering treatment.

Authors:  Konstantinos Tziomalos
Journal:  Panminerva Med       Date:  2016-04-01       Impact factor: 5.197

3.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

4.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

5.  Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Authors:  Stephen J Nicholls; H Bryan Brewer; John J P Kastelein; Kathryn A Krueger; Ming-Dauh Wang; Mingyuan Shao; Bo Hu; Ellen McErlean; Steven E Nissen
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

6.  Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

Authors:  Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden J Manns; Scott Klarenbach; Neesh Pannu; Matthew T James; Brenda R Hemmelgarn
Journal:  Lancet       Date:  2012-06-19       Impact factor: 79.321

7.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

8.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

9.  Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?

Authors:  Vasilios G Athyros; Anna Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Expert Opin Investig Drugs       Date:  2008-04       Impact factor: 6.206

10.  High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.

Authors:  Benjamin Bowe; Yan Xie; Hong Xian; Sumitra Balasubramanian; Mohamed A Zayed; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 8.237

View more
  2 in total

1.  Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison.

Authors:  Bo Zheng; Shinya Goto; Regina Clementi; John Feaster; Danielle Duffy; Penelope Dalitz; Jolanta Airey; Serge Korjian; Michael A Tortorici; John Roberts; C Michael Gibson
Journal:  Clin Transl Sci       Date:  2022-08-07       Impact factor: 4.438

2.  Cuban Sugar Cane Wax Acid and Policosanol Showed Similar Atheroprotective Effects with Inhibition of LDL Oxidation and Cholesteryl Ester Transfer via Enhancement of High-Density Lipoproteins Functionality.

Authors:  Kyung-Hyun Cho; Myung-Ae Bae; Jae-Ryong Kim
Journal:  Cardiovasc Ther       Date:  2019-02-24       Impact factor: 3.023

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.